-
New EU rules on medicines for animals
New EU rules on medicines for animals
-
New EU rules on medicines for animals
New EU rules on medicines for animals
As of 28 January, the Veterinary Medicinal Products Regulation becomes applicable. It aims to increase the availability and access to safe and high-quality veterinary medicines.
-
CHMP highlights: January 2022
CHMP highlights: January 2022
-
CHMP highlights: January 2022
CHMP highlights: January 2022
EMA's human medicines committee (CHMP) recommended seven new medicines for approval at its January 2022 meeting
-
Conditional marketing authorisation for Paxlovid
Conditional marketing authorisation for Paxlovid
-
Conditional marketing authorisation for Paxlovid
Conditional marketing authorisation for Paxlovid
EMA recommends authorising the oral antiviral Paxlovid for treating COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of severe disease
-
Clinical Trials Regulation to enter into application
Clinical Trials Regulation to enter into application
-
Clinical Trials Regulation to enter into application
Clinical Trials Regulation to enter into application
The regulation aims to harmonise the submission, assessment and supervision processes for clinical trials in the EU. Clinical Trials Information System to be launched.
Information for you
Key content
Services & databases
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal